Mono-Mac-6Homo sapiens (Human)Cancer cell line

Also known as: MM6, MONOMAC6, MonoMac6, MonoMac 6, Mono Mac6, Mono Mac 6, MONO-MAC 6, Mono-mac-6, MONO-MAC-6

🤖 AI SummaryBased on 12 publications

Mono-Mac 6

Quick Overview

Human monocytic cell line with characteristics of mature monocytes, used in cancer and immunology research.

Detailed Summary

Mono-Mac 6 is a human monocytic cell line derived from a patient with mononucleosis. It exhibits features of mature monocytes, including CD14 antigen expression, phagocytic ability, and cytokine production. This cell line is widely used as an in vitro model for studying monocyte functions and their role in immune responses. Research on Mono-Mac 6 has contributed to understanding the molecular mechanisms of monocyte activation, cytokine production, and interactions with pathogens. It is also utilized in studies related to leukemia and lymphoma, particularly in investigating the genetic and molecular alterations associated with these malignancies. The cell line's ability to produce cytokines like IL-1, IL-6, and TNF-α makes it valuable for immunological research and drug development.

Research Applications

Cancer researchImmunologyCytokine production studiesLeukemia and lymphoma research

Key Characteristics

CD14 antigen expressionPhagocytic abilityCytokine production (IL-1, IL-6, TNF-α)Mature monocyte-like features
Generated on 6/17/2025

Basic Information

Database IDCVCL_1426
SpeciesHomo sapiens (Human)
Tissue SourcePeripheral blood[UBERON:UBERON_0000178]

Donor Information

Age64
Age CategoryAdult
SexMale

Disease Information

DiseaseAcute monoblastic/monocytic leukemia
LineageMyeloid
SubtypeAcute Monoblastic/Monocytic Leukemia
OncoTree CodeAMOL

DepMap Information

Source TypeDSMZ
Source IDACH-000006_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Arg273His (c.818G>A)Homozygous-Unknown, PubMed=16264262
Gene fusionATP8A2RUNX1-ATP8A2--PubMed=31160637
Gene fusionKMT2AKMT2A-MLLT3, MLL-MLLT3, MLL-AF9--PubMed=31701557

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11,12
D13S317
11,12
D16S539
12
D18S51
13,14
D19S433
13,14
D21S11
30,31.2
D2S1338
19,23
D3S1358
14,18
D5S818
11,12
D7S820
10,11
D8S1179
10,12
FGA
20,22
Penta D
9,11
Penta E
10,11
TH01
8,9.3
TPOX
8,10
vWA
17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

The LL-100 panel: 100 cell lines for blood cancer studies.";

MacLeod R.A.F., Nagel S., Steube K.G., Uphoff C.C., Drexler H.G.

Sci. Rep. 9:8218-8218(2019).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Screening human cell lines for viral infections applying RNA-Seq data analysis.

Uphoff C.C., Pommerenke C., Denkmann S.A., Drexler H.G.

PLoS ONE 14:E0210404-E0210404(2019).

Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.

Yang H.H., Koeffler H.P.

BMC Cancer 18:940.1-940.13(2018).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.

Golub T.R., Root D.E., Hahn W.C.

Sci. Data 1:140035-140035(2014).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.

Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.

Leukemia 20:471-476(2006).

Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations.

Fioretos T.

Leukemia 19:1042-1050(2005).

Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations.

Drexler H.G., Quentmeier H., MacLeod R.A.F.

Leukemia 18:227-232(2004).

Cytokine production of the human monocytic cell line Mono Mac 6 in comparison to mature monocytes in peripheral blood mononuclear cells.

Neustock P., Brand J.M., Kruse A., Kirchner H.

Immunobiology 188:293-302(1993).

Molecular analysis of the Mono Mac 6 cell line: detection of an MLL-AF9 fusion transcript.

Super H.J.G., Martinez-Climent J.A., Rowley J.D.

Blood 85:855-856(1995).

Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes.

Riethmuller G.

Int. J. Cancer 41:456-461(1988).

The leukemia-lymphoma cell line factsbook.";

Drexler H.G.

(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).